Sobiecka Małgorzata, Szturmowicz Monika, Lewandowska Katarzyna B, Barańska Inga, Zimna Katarzyna, Łyżwa Ewa, Dybowska Małgorzata, Langfort Renata, Radwan-Röhrenschef Piotr, Roży Adriana, Tomkowski Witold Z
1st Department of Lung Diseases, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, Poland.
Department of Radiology, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01-138 Warsaw, Poland.
Diagnostics (Basel). 2023 Mar 1;13(5):935. doi: 10.3390/diagnostics13050935.
Fibrotic hypersensitivity pneumonitis (fHP) shares many features with other fibrotic interstitial lung diseases (ILD), and as a result it can be misdiagnosed as idiopathic pulmonary fibrosis (IPF). We aimed to determine the value of bronchoalveolar lavage (BAL) total cell count (TCC) and lymphocytosis in distinguishing fHP and IPF and to evaluate the best cut-off points discriminating these two fibrotic ILD.
A retrospective cohort study of fHP and IPF patients diagnosed between 2005 and 2018 was conducted. Logistic regression was used to evaluate the diagnostic utility of clinical parameters in differentiating between fHP and IPF. Based on the ROC analysis, BAL parameters were evaluated for their diagnostic performance, and optimal diagnostic cut-offs were established.
A total of 136 patients (65 fHP and 71 IPF) were included (mean age 54.97 ± 10.87 vs. 64.00 ± 7.18 years, respectively). BAL TCC and the percentage of lymphocytes were significantly higher in fHP compared to IPF ( < 0.001). BAL lymphocytosis >30% was found in 60% of fHP patients and none of the patients with IPF. The logistic regression revealed that younger age, never smoker status, identified exposure, lower FEV, higher BAL TCC and higher BAL lymphocytosis increased the probability of fibrotic HP diagnosis. The lymphocytosis >20% increased by 25 times the odds of fibrotic HP diagnosis. The optimal cut-off values to differentiate fibrotic HP from IPF were 15 × 10 for TCC and 21% for BAL lymphocytosis with AUC 0.69 and 0.84, respectively.
Increased cellularity and lymphocytosis in BAL persist despite lung fibrosis in HP patients and may be used as important discriminators between IPF and fHP.
纤维化性过敏性肺炎(fHP)与其他纤维化性间质性肺疾病(ILD)有许多共同特征,因此可能被误诊为特发性肺纤维化(IPF)。我们旨在确定支气管肺泡灌洗(BAL)总细胞计数(TCC)和淋巴细胞增多在区分fHP和IPF中的价值,并评估区分这两种纤维化ILD的最佳截断点。
对2005年至2018年间诊断的fHP和IPF患者进行回顾性队列研究。采用逻辑回归评估临床参数在区分fHP和IPF中的诊断效用。基于ROC分析,评估BAL参数的诊断性能,并确定最佳诊断截断值。
共纳入136例患者(65例fHP和71例IPF)(平均年龄分别为54.97±10.87岁和64.00±7.18岁)。与IPF相比,fHP患者的BAL TCC和淋巴细胞百分比显著更高(<0.001)。60%的fHP患者BAL淋巴细胞增多>30%,而IPF患者无一例出现。逻辑回归显示,年龄较小、从不吸烟、明确的暴露史、较低的FEV、较高的BAL TCC和较高的BAL淋巴细胞增多增加了纤维化性HP诊断的可能性。淋巴细胞增多>20%使纤维化性HP诊断的几率增加了25倍。区分纤维化性HP和IPF的最佳截断值分别为TCC为15×10和BAL淋巴细胞增多为21%,AUC分别为0.69和0.84。
尽管HP患者存在肺纤维化,但BAL中的细胞增多和淋巴细胞增多仍然存在,可作为IPF和fHP之间的重要鉴别指标。